SMi proudly presents its inaugural event of the premier Pre-Filled Syringes series to San Diego in June 2016!
The prefilled syringes (PFS) market is poised to account for exponential growth and account for $6 billion revenue by the end of 2020.* The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering. Nonetheless, challenges surrounding biologic drug stability, manufacturing and competition from other drug delivery technologies remain key concerns amongst pharma and medical device manufacturers.
Emulating on SMi’s successful PFS series, we are bringing this must-attend event to the West Coast, where we will focus more on the innovative technologies. Join us today to discuss with your industry colleagues to accelerate PFS development!
For more info visit: www.prefilled-syringes-westcoast.com/bioscreening